American Vanguard Corporation (AVD) AI Stock Analysis

American Vanguard Corporation is a Newport Beach, California-based developer, manufacturer, and marketer of specialty chemicals for agricultural, commercial, and consumer markets worldwide. Founded in 1969, the company produces a comprehensive portfolio of crop protection chemicals including insecticides, fungicides, herbicides, molluscicides, and soil health solutions. Products are formulated in liquid, powder, and granular forms for crop protection, turf management, ornamental plants, and human and animal health. American Vanguard distributes chemical and biological products globally through national distributors, buying groups, cooperatives, and wholly owned distribution networks.

Revenue grew from $557.7M in FY2021 to a peak of $609.6M in FY2022 before declining to $579.4M in FY2023, $547.3M in FY2024, and $515.1M in FY2025, yielding a 5-year CAGR of 2.3%. Profitability weakened significantly over this period, with net income falling from $27.4M in FY2022 to -$126.3M in FY2024 and -$49.9M in FY2025. Gross margin shrank from 39.6% in FY2022 to 28.6% in FY2025. For the trailing twelve months ended June 30, 2026, revenue stood at $510.3M with a profit margin of -10.7% and EPS of -$1.91. In the latest quarter, revenue declined 9.7% year-over-year while earnings dropped 17.6%.

As of June 30, 2026, American Vanguard held $43.9M in cash and short-term investments alongside $284.1M in total debt, resulting in net debt of $240.2M. The company maintains a current ratio of 2.47 and a debt-to-equity ratio of 1.57 on $181.4M of shareholders' equity. In FY2025, operating cash flow was -$21.2M and free cash flow was -$25.3M. Capital allocation in FY2025 included $4.1M for capital expenditures, $2.5M for dividends paid, and $1.4M for share buybacks.

At $1.06 per share, American Vanguard has a market capitalization of $31.3M and an enterprise value of $300.1M. The stock trades at a price-to-sales multiple of 0.1x and an EV-to-EBITDA multiple of 10.5x, matching the median EV-to-EBITDA of 10.5x for its US-listed Basic Materials peers, while its forward P/E of 15.1x is higher than the peer median of 13.4x. Over the past year, the stock fell 80.2%, compared to a 16.8% gain for the S&P 500. Over 5 years, the stock dropped 93.2% while the S&P 500 rose 83.0%.

A single analyst covers American Vanguard for the next fiscal year, establishing a mean price target of $12.00, which represents 1032.1% above the October 16, 2026 closing price of $1.06. For the next fiscal year, the consensus estimates forecast revenue of $555.0M, reflecting 3.5% growth, and EPS of $0.38, an increase of 392.3%. Over the trailing four quarters, the company recorded zero EPS beats. The next earnings date is scheduled for November 9, 2026.

This page is an AI-written research summary of American Vanguard Corporation (AVD). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AVD income statement, AVD balance sheet, AVD key metrics, AVD analyst forecast, AVD chart. See the AVD stock overview for the latest quote and news.